EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Identification of novel protein biomarkers correlating with both cardiac and skeletal muscle indices in duchenne muscular dystrophy

Mark Naguib iD, Katheryn E Gambetta, Jaclyn Tamaroff, William B Burnette, Rachel Harris iD, Meng Xu, Christopher Slaughter, Larry Markham, Christopher Spurney, Jonathan H Soslow, DMDCCC

Journal of Neuromuscular Diseases · 2026-11 · 13 (6) · 1350-1360

DOI: 10.1177/22143602261438533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 15.04.2026. Verfasst von Mark Naguib und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Outreach Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Muscle, Skeletal, Myocardium, Cardiomyopathies. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, FDA HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Duchenne muscular dystrophy (DMD) is marked by cardiac and skeletal myopathy with disparate onset and progression suggesting distinct pathophysiologies. Nontargeted proteomics may elucidate the different disease pathways underlying skeletal muscle and cardiomyopathy progression and identify proteins that improve DMD risk stratification. Methods and results Sixty subjects were enrolled; 56 underwent cardiac magnetic resonance to determine left ventricular ejection fraction, late gadolinium enhancement, and myocardial circumferential strain. Of the 60 patients enrolled, 51 underwent quantitative muscle testing and 33 underwent actigraphy. Aptamer-based technology (SomaScan) evaluated 1128 proteins in plasma. The correlations between serum protein levels and cardiac or skeletal muscle indices were tested using a Spearman correlation test followed by multiple testing correction yielding q -values. The median age was 15.0 years (12.7–17.9 interquartile range). Of 1128 proteins analyzed, 208 correlated with only cardiac indices; 14 correlated with only skeletal muscle indices; 10 proteins correlated strongly with both indices. Protein functions included (1) calcium regulation, (2) cardiac remodeling, (3) cell homeostasis, (4) fibrosis, (5) inflammation, (6) lipid regulation, and (7) other.

Conclusion

Our nontargeted proteomics study identified serum biomarkers correlating with skeletal and cardiac progression in DMD. Candidate proteins—some uniquely associated with skeletal or cardiac indices and others overlapping—offer promising leads for studies to improve risk stratification and guide targeted therapies in DMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneMuscle, SkeletalMyocardiumCardiomyopathiesHumansBiomarkersChildMaleProteomicsAdolescentMagnetic Resonance Imaging

Stichwörter der Autor:innen

cardiomyopathynoninvasive diagnosticsproteomicsrisk stratification

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Outreach Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Division of Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.

ORCID-Profile: Mark Naguib, Rachel Harris

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • FDA HHS
  • NCRR NIH HHS
  • U.S. Food and Drug Administration
  • National Center for Research Resources
  • Fighting Duchenne Foundation and the Fight DMD
  • National Center for Advancing Translational Sciences

Zitieren

APA

Naguib, M., Gambetta, K. E., Tamaroff, J., Burnette, W. B., Harris, R., Xu, M., Slaughter, C., Markham, L., Spurney, C., Soslow, J. H., & DMDCCC (2026). Identification of novel protein biomarkers correlating with both cardiac and skeletal muscle indices in duchenne muscular dystrophy. Journal of Neuromuscular Diseases, 13(6), 1350-1360. https://doi.org/10.1177/22143602261438533

Vancouver

Naguib M, Gambetta KE, Tamaroff J, Burnette WB, Harris R, Xu M, et al. Identification of novel protein biomarkers correlating with both cardiac and skeletal muscle indices in duchenne muscular dystrophy. Journal of Neuromuscular Diseases. 2026;13(6):1350-1360. doi:10.1177/22143602261438533

BibTeX
@article{Naguib2026,
  author = {Naguib, Mark and Gambetta, Katheryn E and Tamaroff, Jaclyn and Burnette, William B and Harris, Rachel and Xu, Meng and Slaughter, Christopher and Markham, Larry and Spurney, Christopher and Soslow, Jonathan H and DMDCCC, DMDCCC},
  title = {Identification of novel protein biomarkers correlating with both cardiac and skeletal muscle indices in duchenne muscular dystrophy},
  journal = {Journal of Neuromuscular Diseases},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {1350--1360},
  doi = {10.1177/22143602261438533}
}
Kostenlos starten →